(Q34214529)

31 July 2017

1 reference

title

Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate (English)

1 reference

31 July 2017

1 reference

Petzinger GM

1

1 reference

31 July 2017

Quik M

2

1 reference

31 July 2017

Ivashina E

3

1 reference

31 July 2017

Jakowec MW

4

1 reference

31 July 2017

Jakubiak M

5

1 reference

31 July 2017

Di Monte D

6

1 reference

31 July 2017

Langston JW

7

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

16

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

202-207

1 reference

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

31 July 2017

cites work

1 reference

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

21 January 2018

1 reference

Sites of the neurotoxic action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the macaque monkey include the ventral tegmental area and the locus coeruleus.

21 January 2018

1 reference

Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

Intracarotid 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism.

21 January 2018

1 reference

Chronic administration of MPTP to monkeys: behavioural morphological and biochemical correlates

21 January 2018

1 reference

Nigrostriatal damage is required for induction of dyskinesias by L-DOPA in squirrel monkeys

21 January 2018

1 reference

Characterisation of dyskinesias induced by L-dopa in MPTP-treated squirrel monkeys

21 January 2018

1 reference

Levodopa-induced dyskinesia and response fluctuations in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

21 January 2018

1 reference

Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).

21 January 2018

1 reference

Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex. The site of drug action and a hypothesis for the neural mechanisms of chorea

21 January 2018

1 reference

Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage

21 January 2018

1 reference

A hypothesis on the pathophysiological mechanisms that underlie levodopa- or dopamine agonist-induced dyskinesia in Parkinson's disease: implications for future strategies in treatment

21 January 2018

1 reference

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

Scales for rating motor impairment in Parkinson's disease: studies of reliability and convergent validity

21 January 2018

1 reference

Evaluating neurological outcome measures: the bare essentials

21 January 2018

1 reference

Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism

21 January 2018

1 reference

Thalamotomy for the alleviation of levodopa-induced dyskinesia: experimental studies in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated parkinsonian monkey

21 January 2018

1 reference

Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis.

21 January 2018

1 reference

Dyskinesias and tolerance induced by chronic treatment with a D1 agonist administered in pulsatile or continuous mode do not correlate with changes of putaminal D1 receptors in drug-naive MPTP monkeys

21 January 2018

1 reference

Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeys

21 January 2018

1 reference

Effect of chronic treatment with (+)-PHNO, a D2 agonist in MPTP-treated monkeys

21 January 2018

1 reference

Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders

21 January 2018

1 reference

Levodopa-induced dyskinesias improved by a glutamate antagonist in Parkinsonian monkeys

21 January 2018

1 reference

Selective D2 receptor stimulation induces dyskinesia in parkinsonian monkeys

21 January 2018

1 reference

Effect of nondopaminergic drugs on L-dopa-induced dyskinesias in MPTP-treated monkeys.

21 January 2018

1 reference

Developing a stable bilateral model of parkinsonism in rhesus monkeys

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.1075

1 reference

31 July 2017

1 reference